Our Science – Blumenthal Website
Robert Blumenthal, Ph.D.
Selected Publications |
 |
| 1)
Afonin KA, Viard M, Martins AN, Lockett SJ, Maciag AE, Freed EO, Heldman E, Jaeger L, Blumenthal R, Shapiro BA. Activation of different split functionalities on re-association of RNA-DNA hybrids. Nat Nanotechnol. 8: 296-304, 2013. [Journal] |
|
| 2)
Kim T, Afonin KA, Viard M, Koyfman AY, Sparks S, Heldman E, Grinberg S, Linder C, Blumenthal RP, Shapiro BA. In Silico, In Vitro, and In Vivo Studies Indicate the Potential Use of Bolaamphiphiles for Therapeutic siRNAs Delivery. Mol Ther Nucleic Acids. 2: e80, 2013. [Journal] |
|
| 3)
Reingewertz TH, Britan-Rosich E, Rotem-Bamberger S, Viard M, Jacobs A, Miller A, Lee JY, Hwang J, Blumenthal R, Kotler M, Friedler A. Mapping the Vif-A3G interaction using peptide arrays: A basis for anti-HIV lead peptides. Bioorg. Med. Chem. [Epub ahead of print], 2013. [Journal] |
|
| 4)
Sinthuvanich C, Veiga AS, Gupta K, Gaspar D, Blumenthal R, Schneider JP. Anticancer beta-Hairpin Peptides: Membrane-Induced Folding Triggers Activity. J. Am. Chem. Soc. 134: 6210-7, 2012. [Journal] |
|
| 5)
Lee JH, Oh H, Baxa U, Raghavan SR, Blumenthal R. Biopolymer-connected liposome networks as injectable biomaterials capable of sustained local drug delivery. Biomacromolecules. 13: 3388-94, 2012. [Journal] |
|
| 6)
Yavlovich A, Viard M, Zhou M, Veenstra TD, Wang JM, Gong W, Heldman E, Blumenthal R, Raviv Y. Ectopic ATP synthase facilitates transfer of HIV-1 from antigen-presenting cells to CD4+ target cells. Blood. 120: 1246-53, 2012. [Journal] |
|
| 7)
Blumenthal R, Durell S, Viard M. HIV viral entry and envelope glycoprotein mediated fusion. J. Biol. Chem. 2012. [Journal] |
|
| 8)
Reuven EM, Dadon Y, Viard M, Manukovsky N, Blumenthal R, Shai Y. HIV-1 gp41 transmembrane domain interacts with the fusion peptide: implication in lipid mixing and inhibition of virus-cell fusion. Biochemistry. 51: 2867-78, 2012. [Journal] |
|
| 9)
Belanger JM, Raviv Y, Viard M, Baxa U, Blumenthal R. Orthogonal inactivation of influenza and the creation of detergent resistant viral aggregates: Towards a novel vaccine strategy. Virol J. 9: 72, 2012. [Journal] |
|
| 10)
Ashkenazi A, Viard M, Unger L, Blumenthal R, Shai Y. Sphingopeptides: dihydrosphingosine-based fusion inhibitors against wild-type and enfuvirtide-resistant HIV-1. FASEB J. 2012. [Journal] |
|
| Click Here to View Expanded Bibliography. |
This page was last updated on 4/5/2013.
